Uncategorized

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is urging Americans to dispose of their prescription medications properly. He addressed the issue in a video posted on X, marking National Prescription Drug Take Back Day, which is April 26.
The Drug Enforcement Administration (DEA) has set up free, anonymous drop-off sites across the country where Americans can leave their unused prescription medications.
RFK JR VOWS TO MAKE SURE KIDS GET 'REAL FOOD,' NOT 'POISON' AFTER ARTIFICIAL FOOD DYE ANNOUNCEMENT
While some may think that flushing prescriptions down the toilet is a safe alternative to throwing them away and can prevent people from accidentally ingesting it, Kennedy warns that there are dangers to that too. The HHS chief explained that once flushed, the medications will go into the water system, potentially exposing anyone who drinks the water to those substances.
“We don’t fully know the effects of low levels of birth control hormones or a..

A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications.
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide).
The injectable prescription medicine is primarily used to treat type 2 diabetes.
OZEMPIC’S HEALTH BENEFITS KEEP GROWING, BUT ARE THE RISKS WORTH IT?
Fetterman was prescribed the medication in July 2025.
“As a stroke survivor, I was interested in studies showing [Mounjaro] could significantly reduce the risk of major cardiac events,” the senator wrote.
“Even though I started taking it for my heart health, I’ve been struck by how much better it has made me feel across the board. It’s made a significant impact on my overall health,” he continued.
“Aches, pains and stiffness have vanished. Physically, I feel a decade younger, as well as clearer-headed and more optimistic than I’d been in years. As far as side effects, I&rsq..

A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications.
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide).
The injectable prescription medicine is primarily used to treat type 2 diabetes.
OZEMPIC’S HEALTH BENEFITS KEEP GROWING, BUT ARE THE RISKS WORTH IT?
Fetterman was prescribed the medication in July 2025.
“As a stroke survivor, I was interested in studies showing [Mounjaro] could significantly reduce the risk of major cardiac events,” the senator wrote.
“Even though I started taking it for my heart health, I’ve been struck by how much better it has made me feel across the board. It’s made a significant impact on my overall health,” he continued.
“Aches, pains and stiffness have vanished. Physically, I feel a decade younger, as well as clearer-headed and more optimistic than I’d been in years. As far as side effects, I&rsq..

A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications.
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide).
The injectable prescription medicine is primarily used to treat type 2 diabetes.
OZEMPIC’S HEALTH BENEFITS KEEP GROWING, BUT ARE THE RISKS WORTH IT?
Fetterman was prescribed the medication in July 2025.
“As a stroke survivor, I was interested in studies showing [Mounjaro] could significantly reduce the risk of major cardiac events,” the senator wrote.
“Even though I started taking it for my heart health, I’ve been struck by how much better it has made me feel across the board. It’s made a significant impact on my overall health,” he continued.
“Aches, pains and stiffness have vanished. Physically, I feel a decade younger, as well as clearer-headed and more optimistic than I’d been in years. As far as side effects, I&rsq..

A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications.
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide).
The injectable prescription medicine is primarily used to treat type 2 diabetes.
OZEMPIC’S HEALTH BENEFITS KEEP GROWING, BUT ARE THE RISKS WORTH IT?
Fetterman was prescribed the medication in July 2025.
“As a stroke survivor, I was interested in studies showing [Mounjaro] could significantly reduce the risk of major cardiac events,” the senator wrote.
“Even though I started taking it for my heart health, I’ve been struck by how much better it has made me feel across the board. It’s made a significant impact on my overall health,” he continued.
“Aches, pains and stiffness have vanished. Physically, I feel a decade younger, as well as clearer-headed and more optimistic than I’d been in years. As far as side effects, I&rsq..

A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications.
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide).
The injectable prescription medicine is primarily used to treat type 2 diabetes.
OZEMPIC’S HEALTH BENEFITS KEEP GROWING, BUT ARE THE RISKS WORTH IT?
Fetterman was prescribed the medication in July 2025.
“As a stroke survivor, I was interested in studies showing [Mounjaro] could significantly reduce the risk of major cardiac events,” the senator wrote.
“Even though I started taking it for my heart health, I’ve been struck by how much better it has made me feel across the board. It’s made a significant impact on my overall health,” he continued.
“Aches, pains and stiffness have vanished. Physically, I feel a decade younger, as well as clearer-headed and more optimistic than I’d been in years. As far as side effects, I&rsq..

A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications.
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide).
The injectable prescription medicine is primarily used to treat type 2 diabetes.
OZEMPIC’S HEALTH BENEFITS KEEP GROWING, BUT ARE THE RISKS WORTH IT?
Fetterman was prescribed the medication in July 2025.
“As a stroke survivor, I was interested in studies showing [Mounjaro] could significantly reduce the risk of major cardiac events,” the senator wrote.
“Even though I started taking it for my heart health, I’ve been struck by how much better it has made me feel across the board. It’s made a significant impact on my overall health,” he continued.
“Aches, pains and stiffness have vanished. Physically, I feel a decade younger, as well as clearer-headed and more optimistic than I’d been in years. As far as side effects, I&rsq..

A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications.
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide).
The injectable prescription medicine is primarily used to treat type 2 diabetes.
OZEMPIC’S HEALTH BENEFITS KEEP GROWING, BUT ARE THE RISKS WORTH IT?
Fetterman was prescribed the medication in July 2025.
“As a stroke survivor, I was interested in studies showing [Mounjaro] could significantly reduce the risk of major cardiac events,” the senator wrote.
“Even though I started taking it for my heart health, I’ve been struck by how much better it has made me feel across the board. It’s made a significant impact on my overall health,” he continued.
“Aches, pains and stiffness have vanished. Physically, I feel a decade younger, as well as clearer-headed and more optimistic than I’d been in years. As far as side effects, I&rsq..

A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications.
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide).
The injectable prescription medicine is primarily used to treat type 2 diabetes.
OZEMPIC’S HEALTH BENEFITS KEEP GROWING, BUT ARE THE RISKS WORTH IT?
Fetterman was prescribed the medication in July 2025.
“As a stroke survivor, I was interested in studies showing [Mounjaro] could significantly reduce the risk of major cardiac events,” the senator wrote.
“Even though I started taking it for my heart health, I’ve been struck by how much better it has made me feel across the board. It’s made a significant impact on my overall health,” he continued.
“Aches, pains and stiffness have vanished. Physically, I feel a decade younger, as well as clearer-headed and more optimistic than I’d been in years. As far as side effects, I&rsq..

A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications.
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide).
The injectable prescription medicine is primarily used to treat type 2 diabetes.
OZEMPIC’S HEALTH BENEFITS KEEP GROWING, BUT ARE THE RISKS WORTH IT?
Fetterman was prescribed the medication in July 2025.
“As a stroke survivor, I was interested in studies showing [Mounjaro] could significantly reduce the risk of major cardiac events,” the senator wrote.
“Even though I started taking it for my heart health, I’ve been struck by how much better it has made me feel across the board. It’s made a significant impact on my overall health,” he continued.
“Aches, pains and stiffness have vanished. Physically, I feel a decade younger, as well as clearer-headed and more optimistic than I’d been in years. As far as side effects, I&rsq..